We are pleased to present our first annual sustainability report, which provides an overview of our Corporate Sustainability Strategy and progress towards each of our aligned UN Sustainable Development Goals (SDGs). Sustainability is at the heart of what we do at bit.bio and we are committed to achieving a more sustainable, equitable, and resilient world for future generations.🌍🌿 Read our full report to learn more about our journey and commitments: https://hubs.ly/Q02GmQYm0 #Sustainability #CorporateResponsibility #SDGs #SustainableFuture #bitbio #COP26 #Impact #SustainableDevelopment
bit.bio
Biotechnology Research
Cambridge, Cambridgeshire 18,161 followers
The Cell Coding Company
About us
bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable research and drug discovery teams to accelerate their experimental timelines and reduce experimental variability, providing an important alternative to traditional workflows. We are also leveraging our platform to build a pipeline of txCells for cell therapies. To achieve our goals, we have assembled a team of pioneers in stem cell biology, cell programming, mathematical modelling and cell therapy. We are empirical, highly ambitious and driven by a shared vision. Collaboration is at the heart of bit.bio. Join us on our journey. For more information on bit.bio’s trademarks, visit www.bit.bio/trademarks
- Website
-
https://bit.bio
External link for bit.bio
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Cambridge, Cambridgeshire
- Type
- Privately Held
- Founded
- 2016
- Specialties
- biotechnology, cell type, life science, pharmaceutical drug discovery, High throughput screening, and cell therapy
Locations
-
Primary
Get directions
The Dorothy Hodgkin Building
Babraham Research Campus
Cambridge, Cambridgeshire CB22 3FH, GB
Employees at bit.bio
Updates
-
It is always incredible to see the real world impact of the research made possible by our ioGlutamatergic Neurons! Read how Charles River Laboratories scientists are developing the first ever antisense oligonucleotide (ASO) for a child with the inherited disorder Dup15q. Click to read more: https://hubs.ly/Q02HLTX30 #CharlesRiver #ioCells #Drugdiscovery
An ASO for Eamonn | Charles River
criver.com
-
In recognition of his impactful achievements within academia and biotech, our SVP of Science, Emmanouil Metzakopian, was invited by the President of Greece to attend a prestigious reception commemorating the 50th anniversary of the restoration of democracy. We are thrilled to see him honored at such a momentous event. “Being part of this milestone celebration of democracy was deeply moving. It reminded me of the important role that society plays in fostering an environment in which scientific innovation and ethical leadership can thrive. The evening reinforced my commitment to contributing positively to these endeavors.”
-
-
Neuroscientists: Co-culture ready human iPSC-derived ioAstrocytes are available now. Simplify lab work for CNS co-cultures, shorten optimisation timelines and focus on your scientific questions with our co-culture protocols. Now complex experimental setups become easy to navigate. Learn more about our ioAstrocytes & ioGlutamatergic Neurons co-culture protocol: https://hubs.ly/Q02HLTdW0 #neuroscience #CNSResearch #neurodegeneration #DrugDiscovery #astrocytes #ioCells #optiox
-
-
NEW DATA ALERT! To develop new therapies for diseases such as muscular dystrophy, there is a pressing need for reliable models of human skeletal muscles. Find out how Bi/ond developed such a model for Duchenne muscular dystrophy using our deterministically programmed human iPSC-derived skeletal myocytes and DMD disease models. Dive into the data by downloading our poster, recently presented at ISSCR! https://hubs.ly/Q02HNYxh0 #musculardystrophy #ioCells #drugdiscovery #skeletalmyocytes
-
-
WEBINAR ALERT! Just 2 weeks to go. Are you looking to develop models of the human brain that better represent human biology? If so, you won’t want to miss our upcoming webinar in collaboration with Inventia Life Science on the 6th of August. Register now: https://hubs.ly/Q02HFCbp0 #webinar #neuroscience #research #DrugDiscovery #3DBiology
-
-
In the final episode of Excedr's Biotech Startups Podcast, CEO Mark Kotter discusses bit.bio's mission to make a meaningful impact on improving healthcare by democratising access to human cells, overcoming early funding challenges and strategic company growth and plans. 🧬 🔗 Listen to Episode 4: https://hubs.ly/Q02Hr7YX0 #bitbio #biotech #podcast #syntheticbiology #stemcells #entrepreneurship #science Jon Chee
Synthetic Biology for Human Health | Cells Reprogrammed | bit.bio
bit.bio
-
In the third of four episodes of Excedr's Biotech Startups Podcast, CEO Mark Kotter discusses vital questions and dynamics that every founder should consider before creating their company, the benefits of founder-led companies and relentless focus on the mission. 🧬 🔗 Listen to Episode 3: https://hubs.ly/Q02H6B1m0 #bitbio #biotech #podcast #syntheticbiology #stemcells #entrepreneurship #science Jon Chee
bit.bio | featured on the Biotech Startups Podcast
bit.bio
-
Are you an experienced Financial Accountant ready to make an impact on the future of science and therapeutics? We are #hiring. We are seeking an experienced Financial Accountant to manage all aspects of financial management. This role includes corporate accounting, regulatory and financial reporting, budget and forecasts preparation, and the development of internal control policies and procedures. 📢 Apply now: https://hubs.ly/Q02H5j8C0 #FinancialAccountant #CambridgeJobs #bitbio #JoinOurTeam #BiotechCareers #AccountingJobs #ScienceAndTherapeutics
-
-
Fantastic to see our cells in action. Thanks Nanolive SA for generating this stunning video.
🔗 𝗡𝗲𝘂𝗿𝗼𝗻𝘀 𝗿𝗲𝗮𝗰𝗵𝗶𝗻𝗴 𝗳𝗼𝗿 𝗰𝗼𝗻𝗻𝗲𝗰𝘁𝗶𝗼𝗻 🔗 High temporal resolution reveals the fine details of growth cone dynamics in real-time as a neuron searches for another cell. We see undulating movements of the growth cone and the long filopodia as actin bundles are restructured, thanks to the label-free, high spatial resolution of Nanolive imaging. Can you spot the transport of materials away from the cell body too? Many thanks to bit.bio for providing us with these ioGlutamatergic neurons! #nanolive #biotechnology #imaging #neuroscience #neurons #technology #sciencecommunication #medtech #innovation #medicine #research